Quinoline-6-boronic acid, pinacol ester
Product Information
Molecular Formula
C15H18BNO2
Molecular Weight
255.12
Description
Quinoline-6-boronic acid, pinacol ester is a vital compound in biomedicine and is utilized in the development of various drugs targeting diseases like cancer, diabetes, and infections. This product plays a crucial role as a building block in the synthesis of therapeutic agents that aim to combat these conditions, contributing to advancements in the biomedical field.
Synonyms
6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline
IUPAC Name
6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline
SMILES
B1(OC(C(O1)(C)C)(C)C)C2=CC3=C(C=C2)N=CC=C3
InChI
InChI=1S/C15H18BNO2/c1-14(2)15(3,4)19-16(18-14)12-7-8-13-11(10-12)6-5-9-17-13/h5-10H,1-4H3
InChI Key
VMFALDWCEQUFSX-UHFFFAOYSA-N
Melting Point
62-66 °C (lit.)
Flash Point
Not applicable
Purity
95%
Appearance
White to light orange solid
Safety Information
Hazards
H315 - H319 - H335
Precautionary Statement
P302 + P352 - P305 + P351 + P338
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
3
Rotatable Bond Count
1
Exact Mass
255.1430590 g/mol
Monoisotopic Mass
255.1430590 g/mol
Topological Polar Surface Area
31.4Ų
Heavy Atom Count
19
Formal Charge
0
Complexity
329
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| CN-113957441-A | Etching solution and preparation method and application thereof | 2021-10-29 |
| CN-113264937-A | 4-aminopyrazolo [3,4-d ] pyrimidine derivative and application thereof | 2021-06-08 |
| CN-111253202-A | Fluorene derivative and preparation method and application thereof | 2020-02-24 |
| US-2021214366-A1 | Bicyclic heterocycles as fgfr inhibitors | 2020-01-15 |
| WO-2021139775-A1 | Pyridone compound and application | 2020-01-10 |
| WO-2021035101-A1 | Molecules that bind to tdp-43 for the treatment of amyotrophic lateral sclerosis and related disorders | 2019-08-22 |
| US-2020231589-A1 | 1,8-naphthyridinone compounds and uses thereof | 2019-01-18 |
| WO-2020150676-A1 | 1,8-naphthyridinone compounds and uses thereof | 2019-01-18 |
| AU-2020207951-A1 | 1,8-naphthyridinone compounds and uses thereof | 2019-01-18 |
| CN-113939291-A | 1, 8-naphthyridinone compounds and uses thereof | 2019-01-18 |
